Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The company said its programme at the 35th European Academy of Dermatology and Venereology Congress in Vienna includes more than 20 abstracts, late-breaking data and two expert symposia. It highlighted new evidence for lebrikizumab, tildrakizumab, CAL/BDP PAD cream and tirbanibulin across atopic dermatitis, psoriasis a
Almirall, S.A. (ALM), a global biopharmaceutical company dedicated to medical dermatology, today announced its scientific programme at the 35th European Academy of Dermatology and Venereology (EADV) Congress, taking place in Vienna from 30 September to 3 October 2026. As Gold Sponsor of this year’s…